Pepsinogen and Serum IgG Detection Is a Valuable Diagnostic Method for Helicobacter pylori Infection in a Low-Prevalence Country: A Report from Sri Lanka
Open Access
- 29 July 2021
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 11 (8), 1364
- https://doi.org/10.3390/diagnostics11081364
Abstract
The use of serum anti-Helicobacter pylori IgG and pepsinogen (PG) detection as a diagnostic method was evaluated in Sri Lanka. Gastric biopsies were performed (353 patients), and the prevalence of H. pylori infection was 1.7% (culture) and 2.0% (histology). IgG serology testing showed an area under the curve (AUC) of 0.922 (cut-off, 2.95 U/mL; specificity, 91.56%; sensitivity, 88.89%). Histological evaluation showed mild atrophy (34.3%), moderate atrophy (1.7%), metaplasia (1.7%), chronic gastritis (6.2%), and normal tissue (56%). The PGI/PGII ratio was significantly higher in H. pylori-negative patients (p < 0.01). PGII and PGI/PGII levels were lower in patients with metaplasia than in those with normal mucosa (p = 0.049 and p < 0.001, respectively). The PGI/PGII ratio best discriminated metaplasia and moderate atrophy (AUC 0.88 and 0.76, respectively). PGI and PGII alone showed poor discriminative ability, especially in mild atrophy (0.55 and 0.53, respectively) and chronic gastritis (0.55 and 0.53, respectively). The best cut-off to discriminate metaplasia was 3.25 U/mL (95.19% specificity, 83.33% sensitivity). Anti-H. pylori IgG and PG assessment (ABC method) was performed (group B, 2.0%; group A, 92.1%). The new cut-off more accurately identified patients with metaplasia requiring follow-up (group B, 5.4%). Assessment of anti-H. pylori IgG and PG is valuable in countries with a low prevalence of H. pylori infection.Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (DK62813,, 221S0002, 16H06279, 18KK0266, 18K16182, 17K09353)
- Japan Society for the Promotion of Science (Young Researcher Overseas Visits)
- Japan Science and Technology Agency (Strategic Funds)
This publication has 60 references indexed in Scilit:
- The gastric precancerous cascadeJournal of Digestive Diseases, 2011
- Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - "ABC method"Proceedings of the Japan Academy, Series B, 2011
- The Role of Serum Pepsinogen in the Detection of Gastric CancerGut and Liver, 2010
- Helicobacterand Gastric MalignanciesHelicobacter, 2008
- Helicobacter pylori outer membrane proteins and gastroduodenal diseaseGut, 2006
- Racial differences in Helicobacter pylori, serum pepsinogen and gastric cancer incidence in an urban Asian populationJournal of Gastroenterology and Hepatology, 2005
- Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspepticsBritish Journal of Cancer, 2003
- Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infectionThe Lancet, 1995
- Clinical Application of Serum Pepsinogen I and II Levels for Mass Screening to Detect Gastric CancerJapanese Journal of Cancer Research, 1993
- Methylation and Expression of Human Pepsinogen Genes in Normal Tissues and Their Alteration in Stomach CancerJapanese Journal of Cancer Research, 1991